SHAHID NAWAZ MD NPI 1700880465

NPI Information

  • NPI: 1700880465
  • Provider Name: SHAHID NAWAZ, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 285 SILLS RD BLDG 16
    EAST PATCHOGUE, NY
    ZIP 11772
  • Phone: (631) 751-3000

Map and Directions

Get Directions

NPI Details

Shahid Nawaz, MD is a hematology and oncology internal medicine in East Patchogue, NY with 39 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Shahid Nawaz, MD NPI is 1700880465. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

285 SILLS RD BLDG 16
EAST PATCHOGUE, NY
ZIP 11772-808
Phone: (631) 751-3000
Fax: (631) 509-6559

The NPI 1700880465 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Magnesium level (HCPCS:83735)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Phosphate level (HCPCS:84100)
  • Uric acid level, blood (HCPCS:84550)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Folic acid level, serum (HCPCS:82746)
  • Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Vitamin d-3 level (HCPCS:82306)
  • Protein measurement, serum (HCPCS:84165)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Ige (immune system protein) level (HCPCS:82785)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Red blood count, manual test (HCPCS:85044)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Measurement c-reactive protein for detection of infection or inflammation, high sensitivity (HCPCS:86141)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Blood test, clotting time (HCPCS:85610)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Testosterone (hormone) level, total (HCPCS:84403)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Hemoglobin a1c level (HCPCS:83036)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
  • Thyroxine (thyroid chemical), total (HCPCS:84436)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Acute hepatitis panel (HCPCS:80074)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Bilirubin level, total (HCPCS:82247)
  • Urinalysis, manual test (HCPCS:81002)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
  • Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
  • Influenza vaccine split virus, preservative free (HCPCS:90662)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Transitional care management services for problem of high complexity (HCPCS:99496)
  • Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
  • Blood test, basic group of blood chemicals (calcium, ionized) (HCPCS:80047)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
  • Rheumatoid factor level (HCPCS:86431)
  • Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99426)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Red blood cell concentration measurement (HCPCS:85014)
  • Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)
  • Molecular pathology procedure; physician interpretation and report (HCPCS:G0452)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Gene analysis (calreticulin), common variants (HCPCS:81219)
  • Gene analysis (janus kinase 2) variant (HCPCS:81270)
  • Gene analysis (janus kinase 2) targeted sequence analysis (HCPCS:81279)
  • Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants (HCPCS:81338)
  • Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99439)
  • Parathormone (parathyroid hormone) level (HCPCS:83970)
  • Transitional care management services for problem of moderate complexity (HCPCS:99495)
  • Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)

The enumeration date for this NPI number is 6/10/2005 and was last updated on 1/31/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology200023NEW YORKYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
102490128MEDICAIDNEW YORK

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.